| Drug Name |
Rabeprazole sodium |
| Drug ID |
BADD_D01899 |
| Description |
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion. |
| Indications and Usage |
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use. |
| Marketing Status |
approved; investigational |
| ATC Code |
A02BC07; A02BC04 |
| DrugBank ID |
DB01129
|
| KEGG ID |
D00724
|
| MeSH ID |
D064750
|
| PubChem ID |
14720269
|
| TTD Drug ID |
D0KL4J
|
| NDC Product Code |
50090-4751; 55111-055; 65372-1132; 62135-503; 68788-7657; 70518-2590; 71335-0027; 52286-0017; 53104-7568; 51407-184; 68788-7459; 71335-1558; 72189-169; 60760-972; 61919-467; 67877-443; 70518-2860; 76420-223; 45865-123; 45865-802; 63187-788; 76420-107; 80425-0134; 42765-013; 51148-006; 13668-107; 55700-767; 63187-259; 63187-555; 68180-220; 69784-243; 71335-0244; 62175-302; 65862-721; 71335-1100; 60760-560; 62856-243; 70518-3209; 80425-0094; 52932-0736; 53069-0980; 65862-414; 65977-0033; 53069-0650; 71205-292; 71205-603; 72189-142; 72888-059; 51148-005 |
| UNII |
3L36P16U4R
|
| Synonyms |
Rabeprazole | 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole | Dexrabeprazole | E 3810 | E3810 | Pariet | Rabeprazole Sodium | Sodium, Rabeprazole | 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt | Aciphex | LY-307640 | LY 307640 | LY307640 |
